Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)

Arpita P Gandhi; Michèle L. Donato; Themba Nyirenda; David H. Vesole; Andrew L. Pecora; Stuart L. Goldberg; André Goy; Tatyana Feldman; Anthony R. Mato; Pritish K. Bhattacharyya

doi:10.1182/blood.v122.21.4545.4545

Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)

Identifier:nobleid.org/w1/20260515/D6FD99C8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D6FD99C8.svg?ark=w1%2F20260515%2FD6FD99C8)](https://nobleid.org/work/w1/20260515/D6FD99C8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Pritish K. Bhattacharyya

Claim authorship of this work

Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)

Identifier:nobleid.org/w1/20260515/D6FD99C8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D6FD99C8.svg?ark=w1%2F20260515%2FD6FD99C8)](https://nobleid.org/work/w1/20260515/D6FD99C8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Pritish K. Bhattacharyya

Claim authorship of this work